Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries
- PMID: 26007151
- DOI: 10.1007/s00296-015-3275-4
Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries
Abstract
The objective of this study was to evaluate the influence of morning stiffness on productivity at work and to estimate the work-related economic consequences of morning stiffness among patients with RA-related morning stiffness in 11 European countries. The original sample comprised 1061 RA patients from 11 European countries (Belgium, Denmark, Finland, France, Germany, Italy, Norway, Poland, Spain, Sweden and UK). They had been diagnosed with RA and experience morning stiffness three or more times per week. Data were collected by interviews. Women comprised 77.9 % of the sample, the average age was 50.4 years, and 84.3 % had RA diagnosed for more than 2 years. Overall costs of RA-related morning stiffness was calculated to be 27,712€ per patient per year, varying from 4965€ in Spain to 66,706€ in Norway. On average, 96 % of the overall production losses were attributed to early retirement, with a markedly lower level (77 %) in Italy than in other countries (p < 0.0001). The proportion of patients who reported retirement due to morning stiffness and productivity losses due to late work arrivals and working while sick showed considerable variation across the countries represented in the study. Overall, the average annual cost of late arrivals (0.8 % of the total costs) was approximately half of the costs attributed to sick leave (1.7 %) and working while sick (1.5 %). Morning stiffness due to RA causes significant production losses and is a significant cost burden throughout Europe. There seem to be notable differences in the impact of morning stiffness on productivity between European countries.
Keywords: Early retirement; Indirect costs; Morning stiffness; Production loss; Rheumatoid arthritis.
Similar articles
-
Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis.Rheumatol Int. 2014 Dec;34(12):1751-8. doi: 10.1007/s00296-014-3040-0. Epub 2014 May 29. Rheumatol Int. 2014. PMID: 24871158 Free PMC article.
-
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.Arthritis Care Res (Hoboken). 2013 Oct;65(10):1564-72. doi: 10.1002/acr.22022. Arthritis Care Res (Hoboken). 2013. PMID: 23554320
-
The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.Med Care. 2006 Apr;44(4):304-10. doi: 10.1097/01.mlr.0000204257.25875.04. Med Care. 2006. PMID: 16565630
-
Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.Best Pract Res Clin Rheumatol. 2015 Jun;29(3):495-511. doi: 10.1016/j.berh.2015.06.001. Epub 2015 Jul 14. Best Pract Res Clin Rheumatol. 2015. PMID: 26612244 Review.
-
Quantifying the economic burden of productivity loss in rheumatoid arthritis.Rheumatology (Oxford). 2011 Jun;50(6):1083-90. doi: 10.1093/rheumatology/keq399. Epub 2011 Jan 18. Rheumatology (Oxford). 2011. PMID: 21245074 Review.
Cited by
-
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.Rheumatol Int. 2019 Dec;39(12):2015-2024. doi: 10.1007/s00296-019-04378-6. Epub 2019 Aug 8. Rheumatol Int. 2019. PMID: 31396685
-
New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.PLoS One. 2019 May 28;14(5):e0217412. doi: 10.1371/journal.pone.0217412. eCollection 2019. PLoS One. 2019. PMID: 31136632 Free PMC article.
-
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.Clin Rheumatol. 2020 Sep;39(9):2583-2592. doi: 10.1007/s10067-020-05038-y. Epub 2020 Mar 23. Clin Rheumatol. 2020. PMID: 32206973 Free PMC article.
-
Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018.J Rheumatol. 2019 Oct;46(10):1374-1378. doi: 10.3899/jrheum.181074. Epub 2019 Feb 15. J Rheumatol. 2019. PMID: 30770511 Free PMC article.
-
Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review.Ther Clin Risk Manag. 2016 Nov 21;12:1763-1776. doi: 10.2147/TCRM.S112685. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27920546 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical